sysvasc.eu
PARTNERS | sysVASC
http://www.sysvasc.eu/partners
MEDICAL UNIVERSITY OF GRAZ. BAKER IDI HEART & DIABETES INSTITUTE. SWISS INSTITUTE OF BIOINFORMATICS. UNIVERSITY OF BRITISH COLUMBIA. NEWS & MEDIA. MEDICAL UNIVERSITY OF GRAZ. BAKER IDIHEART and DIABETES INSTITUTE. SWISS INSTITUTE FOR BIOINFORMATICS. UNIVERSITY OF BRITISH COLUMBIA. This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no: 603288. 2014 / webdesign by biolution GmbH.
sysvasc.eu
SERVICEXS | sysVASC
http://www.sysvasc.eu/servicexs
MEDICAL UNIVERSITY OF GRAZ. BAKER IDI HEART & DIABETES INSTITUTE. SWISS INSTITUTE OF BIOINFORMATICS. UNIVERSITY OF BRITISH COLUMBIA. NEWS & MEDIA. ServiceXS is an expert in genomic analysis, including next generation and whole genome sequencing. Within sysVASC, ServiceXS will contribute whole genome sequencing, miRNAomics, and relevant bioinformatics tools for advanced dynamic modelling and model based cluster analysis. Prof Dr. Bart Janssen. Http:/ www.servicexs.com/. Http:/ diabetes.diabetesjournal...
sympath-project.eu
PARTNERS – sympath-project
http://sympath-project.eu/partners
VISIT TO VIENNA CITY HALL. Prof Wassilios Meissner,. A leading international expert for diagnosis and treatment of multiple-system atrophy and Parkinson s disease,. Claire Levy Marchal , MD, MSc,. Is a clinical research coordinator at INSERM, she is also coordinating the F-CRIN from its start-up in 2011 and the CIC (Clinical Investigation Centers) network in France for many years . Dr Levy Marchal has published more than 150 articles in International scientific journals. Dieter VOLC, MD.
euthyroid.eu
PARTNERS | EUthyroid Project
http://euthyroid.eu/partners
PARTNERS – EUthyroid Project. Towards a euthyroid europe! 22 Member States of the EU participate in EUthyroid as partner, corresponding to 94% of the Union’s population and in addition five countries from the IGN West Central Europe group are involved (Iceland, Israel, Macedonia, Norway and Switzerland). If you are looking for a partner in your country please use the search tool below. University Medicine Greifswald, DE. National Institute for Health and Welfare, FI. Iodine Global Network, CA. Sofia Univ...
tobi-project.eu
TOBI - Partners
http://www.tobi-project.eu/html_en/partners.html
Medical University of Vienna - Coordinator. More than 100 bariatric operations, i.e. surgical interventions to support weight loss, are annually performed at the Dept. of Surgery (senior physician Assoc.Prof. Dr. Gerhard Prager). With steadily increasing rates giving rise to ample opportunities to collect samples of subcutaneous and visceral adipose tissue in clinical studies. Listed on Alternext by Euronext™ Paris (ALGFT - FR0004163111), Genfit is an innovative biopharmaceutical company headquarte...
modicell.eu
THE PROJECT - MODICELL
http://www.modicell.eu/index.php/the-project
Contact us via email. Sets out to improve the understanding of the complexity of immune cell responses by studying cells designed for therapies. In the settings of cancer or transplantation and implement bioinformatics. And in silico immune modeling. To better understand the dynamics and plasticity of immune cell populations. In future medical intervention. LEGAL DETAILS and CONTACT. The Project recieves funding from the European Union FP7-People Programme under grant agreement n 285875.
modicell.eu
BAR ILAN UNIVERSITY - MODICELL
http://www.modicell.eu/index.php/bar-ilan-university
Contact us via email. Sol Efroni is the group leader of the System’s Biomedicine Lab at Bar Ilan University, Tel Aviv, Israel. One main focus of his and his group’s research is to study transcriptional network alterations that are the core difference between a healthy tissue and a sick tissue. His research utilizes genome-wide, high-throughput analyses platforms and is aimed to cope with this genome-wide, network entangled, complexity. BAR ILAN UNIVERSITY IN THE MODICELL PROJECT:.
modicell.eu
OVERALL OBJECTIVE - MODICELL
http://modicell.eu/index.php/overallo
Contact us via email. The overall objective of the project MODICELL. Is to improve the therapeutic efficacy of immune cell therapies, which are currently a main area of research in cancer and transplantation. Cancer and transplantation are among the most frequent conditions world-wide, in which immune system alterations play a critical role. In these diseases, immune system alterations involve opposite ends:. Immune paralysis prevailing in cancer progression and. LEGAL DETAILS and CONTACT.
tobi-project.eu
TOBI - Media
http://www.tobi-project.eu/html_en/disclaimer.html
DISCLOSURE ACCORDING TO 25 MeDIA ACT (AUSTRIA). Medizinische Universität Wien, Spitalgasse 23, 1090 Wien. Represented ny rector Mr. O.Univ. Prof. Dr. Wolfgang Schütz. Inspectorate of the Medical University of Vienna. Bundesministerium für Wissenschaft, Forschung und Wirtschaft BMWFW. Webdesign, programming and text editing. In the case of a technical problem, please contact.
